A Cohort Study for the Following up of Conization
Oncologic and Obstetric Outcomes After Conization for Uterine Cervical Lesion: A Cohort Study
1 other identifier
observational
10,000
1 country
1
Brief Summary
This study is to investigate the oncologic and obstetric outcomes in patients with conization for uterine cervical lesions from January 1, 2000 to January 1, 2019 in Peking Union Medical College Hospital. The primary objectives consist of following:
- 1.The cumulative incidences of precancerous lesions and cancers of lower genital tract in patients who accepted conization for high grade intraepithelial neoplasia (HSIL), carcinoma in situ and stage IA1 cancer (FIGO 2009)
- 2.The cumulative pregnancy rates in patients sparing the fertility
- 3.The effects of surgical protocols (modified Sturmdorf method and "8" figure suture) and energy equipment (cold knife and monopolar electrical cautery) on the oncologic and obstetric outcomes, and on the histological components.
- 4.A full description of histological components of the conization specimens
- 5.The cytological and virus outcomes after conization, based on the thin prep liquid-based cytology test (TCT) and high-risk human papillomavirus (HPV) testing
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2019
CompletedFirst Posted
Study publicly available on registry
May 23, 2019
CompletedStudy Start
First participant enrolled
June 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2021
CompletedJune 20, 2019
June 1, 2019
2 years
May 22, 2019
June 19, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
The cumulative incidences of precancerous lesions or cancers
The cumulative incidences of precancerous lesions and cancers of lower genital track in patients who accepted conization for high grade intraepithelial neoplasia (HSIL), carcinoma in situ and stage IA1 cancer (FIGO 2009)
Five years
The cumulative pregnancy rates
The cumulative pregnancy rates in patients sparing the fertility
Five years
Secondary Outcomes (4)
The cytological results after conization
Five years
The virus outcomes after conization
Five years
The cumulative pregnancy loss rates
Five years
The cumulative live birth rates
Five years
Interventions
High-risk HPV testing for the cytology of lower genital tract
Thin prep liquid-based cytology test for the cytology of lower genital tract
Eligibility Criteria
The study population consists of patients accepting conization in the study center who were aged 18 years or older.
You may qualify if:
- Accepting conization in the study center
- Aged 18 years or older
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lei Lilead
Study Sites (1)
Lei Li
Beijing, Beijing Municipality, 100730, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Li, M.D.
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2019
First Posted
May 23, 2019
Study Start
June 3, 2019
Primary Completion
May 22, 2021
Study Completion
May 22, 2021
Last Updated
June 20, 2019
Record last verified: 2019-06